The LifeArc Translational Science Summit has been confirmed for 12th May 2026 at the Business Design Centre in London.
The event will delve into how translational research accelerates the journey from scientific discovery to real-world impact – particularly in rare diseases – by advancing treatments, shaping clinical practice, influencing health policy, and driving commercial innovation. It will bring together leading scientists, clinicians, industry experts, policy makers, and investors to share insights and foster collaboration.
A stellar line-up has already been announced, including:
- Lucy Lehane, Scientific Advisor, BIVDA
- Melanie Ivarsson, CEO, HDRS
-
Alastair Denniston, Professor of Regulatory Science and Innovation, University of Birmingham
- Chris Molloy, CEO, BIA
You can apply to attend by clicking here.
